Ledger.Open graph →
SEC Form D · filed April 15, 2022

Akston Biosciences Corp

Offering
$10.0M
Sold
$5.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BEVERLY, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

James M. Herriman · BEVERLY, MAExecThomas M. Lancaster · BEVERLY, MAExec · DirectorLovick E. Cannon · BEVERLY, MADirectorTodd C. Zion · BEVERLY, MAExec · DirectorRobyn M. Davis · BEVERLY, MADirectorShahan Soghikian · SAN FRANCISCO, CAExecChris Albinson · SAN FRANCISCO, CAExec · DirectorJohn Moragne · SAN FRANCISCO, CAExec · DirectorMichael Fordyce · SAN FRANCISCO, CADirectorRoisin Addlestone · Grand Cayman, Cayman IslandsDirectorSSI Investment Management LLC · Beverly Hills, CADirectorOliver B. Keller · Boston, MADirectorMary E. Alexander · Fayetteville, ARExecStephen C. Malloy · Fayetteville, ARExec · DirectorDonald L. Hawks Iii · Stamford, CTExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗